1. Home
  2. BMRN vs WSO Comparison

BMRN vs WSO Comparison

Compare BMRN & WSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

N/A

Current Price

$66.53

Market Cap

13.0B

Sector

Health Care

ML Signal

N/A

Logo Watsco Inc.

WSO

Watsco Inc.

N/A

Current Price

$315.13

Market Cap

13.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
BMRN
WSO
Founded
1996
1945
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
13.0B
13.6B
IPO Year
1999
1994

Fundamental Metrics

Financial Performance
Metric
BMRN
WSO
Price
$66.53
$315.13
Analyst Decision
Buy
Hold
Analyst Count
18
6
Target Price
$88.22
$399.00
AVG Volume (30 Days)
2.2M
478.0K
Earning Date
05-04-2026
04-28-2026
Dividend Yield
N/A
3.08%
EPS Growth
N/A
N/A
EPS
0.77
5.92
Revenue
$1,313,646,000.00
$7,239,290,000.00
Revenue This Year
$15.02
$3.02
Revenue Next Year
$12.23
$5.20
P/E Ratio
$86.55
$53.16
Revenue Growth
17.62
N/A
52 Week Low
$49.26
$295.75
52 Week High
$70.98
$459.00

Technical Indicators

Market Signals
Indicator
BMRN
WSO
Relative Strength Index (RSI) 56.83 44.23
Support Level $58.03 $301.25
Resistance Level $70.98 $323.89
Average True Range (ATR) 1.56 9.15
MACD -0.34 2.45
Stochastic Oscillator 46.31 67.43

Price Performance

Historical Comparison
BMRN
WSO

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

About WSO Watsco Inc.

Watsco is the largest HVAC and refrigeration products distributor in North America with approximately 13% market share. The company primarily operates in the United States (90% of revenue) with significant exposure in the Sunbelt states. Watsco also has operations in Canada, Latin America, and the Caribbean. The company's customer base comprises more than 120,000 dealers and contractors serving the replacement and new-construction HVAC/R markets for residential and light-commercial applications. As much as 20% of residential HVAC units are distributed through Watsco in any given year. Revenue is approximately 75%-80% residential HVAC and 20%-25% commercial, with relatively small exposure to more complex "applied" solutions.

Share on Social Networks: